Literature DB >> 22810148

DFPE, partially fluorinated ether: a novel approach for experimental intravitreal tamponade.

Rodrigo A V Santos1, David J Keegan, Brian S Fuchs, Brian J Song, Marcos P Avila, Nigel Simpson, Janet R Sparrow, Stanley Chang.   

Abstract

PURPOSE: To evaluate decafluoro-di-n-pentyl ether (DFPE) as a vitreous tamponade by examining ocular tolerance in rabbits' eyes.
METHODS: Thirteen rabbits were divided into 4 groups after mechanical vitrectomy and were followed up to 12 months. The tamponade remained in the eye for 6 months in group 1 (DFPE) and Group 3 (DFPE and silicone oil) and for 12 months in group 2 (DFPE). Group 4 served as control.
RESULTS: In groups 1, 2, and 3, dispersion of the fluid appeared 2 weeks postoperatively. Posterior subcapsular cataracts appeared in rabbits' eyes with large fills of DFPE (>50%). Histologic findings in groups 1 and 2 showed no detectable change in outer nuclear layer thickness. Except for some vacuolations, the inner retina was well preserved in all injected rabbits' eyes. On the electroretinography of injected rabbits' eyes, there was no effect on the a wave amplitude and b wave implicit time, but the b wave amplitude was elevated with statistical significance (P < 0.001) at 1, 3, and 6 months postoperatively but with no statistical significance (P > 0.05) after that period when compared with group 4 and unoperated fellow rabbits' eyes of each group.
CONCLUSION: Decafluoro-di-n-pentyl ether demonstrated minimum adverse effects in retinal rabbits; further studies are needed before clinical use as short-term tamponade.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22810148     DOI: 10.1097/IAE.0b013e31825db6cf

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  1 in total

1.  Preliminary study of the safety and efficacy of medium-chain triglycerides for use as an intraocular tamponading agent in minipigs.

Authors:  Vincent J Soler; Camille Laurent; Frédéric Sakr; Alain Regnier; Cyrielle Tricoire; Olivier Cases; Renata Kozyraki; Jean-Yves Douet; Véronique Pagot-Mathis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-25       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.